Products and Resources Catalog

  Supplemental webinar resources: Webinar presentation MEE Productions Newsletter: Engaging and Mobilizing the Grassroots Community - How to Work with CBOs MEE Productions Newsletter: Tackling America’s Opioid Epidemic from the Ground Up MEE Productions Newsletter: Effectively Engaging Men and Fathers to Support the Health and Wellness of Their Families MEE Productions Newsletter: Community Engagement 101 Infographic: The Win-Win of Community Engagement Infographic: Framing of Opioid Misuse   Presented by: Ivan J. Juzang, MBA, Founder and President of MEE Productions Inc. Description: Many agencies and organizations are struggling to engage members of affected communities with opioid prevention, recovery and treatment messaging, due to stigma related to addiction, ineffective outreach and engagement strategies, low levels of trust in government institutions and other challenges. During this webinar, MEE will share how Coalitions or Collaborations in any size community can enhance their outreach, engagement and prevention efforts, with a focus on hard-to-reach audiences. These strategies and tactics will help them grow their presence in both digital (online) and grassroots (off-line) spheres to educate communities and to mobilize partners and stakeholders, increasing both impact and effectiveness of their opioid prevention and reduction efforts. Learning Objectives: 1. Participants will understand MEE's Adaptation of the SPF Model (By-and-For Processes) to engage communities from oral-based cultures 2. Participants will understand why a mix of strategies results in the Most Effective Community Engagement Efforts 3. Participants will learn How to Use Community-Engagement Tactics in their Substance Misuse Prevention Work to Counter a Lack of Trust About Ivan J. Juzang, MBA Ivan Juzang, MBA, Founder and President of MEE Productions Inc., is a leading expert in health communications and social marketing. He has over 25 years of first-hand experience working on health disparities and public health issues affecting low income, underserved and devalued communities across America. Mr. Juzang’s work focuses on how service providers, community-based organizations and the public health community can present trauma-informed and culturally-relevant health information in such a way that lifestyle changes are sustainable in the context of an economically-challenged and stressed-out life. MEE specializes in community-centered approaches that acknowledge the social determinants of health, honor personal assets and resiliency, infuse protective factors and embrace trauma-informed strategies. MEE has been engaged in substance abuse prevention work since 1991 in low-income urban communities across the country. Its specific opioid misuse work has been conducted in urban, suburban and rural communities over the last five years, in places that include Philadelphia, Baltimore and New Orleans, with Prevention Coalitions across Ohio and statewide agencies in Louisiana. Mr. Juzang was a member of the Advisory Committee on Public Issues for The Ad Council and a current board member of Power to Decide (formerly the National Campaign to Prevent Teen and Unplanned Pregnancy). From 2003-2009, Mr. Juzang was a member of The Office of National Drug Control and Policy's Behavior Change Expert Panel. Mr. Juzang received his BS degree in Mechanical Engineering from Carnegie-Mellon University, and his MBA from The Wharton School of Business.  

COURSE DESCRIPTION The lecture will provide an understanding of the current opioid epidemic and the confluences of factors that paved the way for our current state of unprecedented high rates of overdose deaths. The course will discuss and define harm reduction, and focus on one tool that is currently being employed to reduce overdose among people who use drugs (PWUD). Ultimately, the course will discuss data from studies that demonstrate PWUDs’ ability and implementation of novel life saving methods. LEARNING OBJECTIVES To learn about the phases of opioid epidemic, that resulted in the current state of a highly adulterated drug market. To understand harm reduction as a holistic response to the overdose epidemic. To learn about the history of drug checking, validated technologies, and the evidence that supports acceptability among people who use drugs. Learn about the policy barriers and facilitators of implementing drug checking as a part of a holistic response to the opioid epidemic. PRESENTER Dr. Susan Sherman is a Professor at the Johns Hopkins Bloomberg School of Public Health Behavior and Society.  She is a social scientist whose focuses on the documenting and intervening on structural drivers of HIV/STIs and violence among people who use drugs and engage in sex work. She has conducted extensive research in India, Thailand, and Pakistan examining the role of microeconomics and peer influence on reducing HIV risk among people who use drugs and women who sell sex.  She is the Co-Director of the Baltimore HIV Collaboratory as well as the Addiction and Overdose focus area of the Bloomberg American Health Initiative.  She has recently examined the validity, acceptability, and implementation of several fentanyl testing technologies. That study led to a change in the law in Maryland regarding the legality of drug checking and informed programs  throughout the U.S.                  

Click the buttons below to view this webinar translated in Spanish or Portuguese     This webinar will provide an overview of suicide prevention with the intention of encouraging participants to be available to prevent suicide within the people they interact with. Facilitator will discuss warning signs and risk factors for suicide. National data, youth data, including suicide among Latinos and other relevant data will be presented. The webinar will discuss the effects of this “forever decision” which is preventable. The facilitator will present her experience as the suicide prevention project coordinator at CETPA Inc. Lastly, suicide prevention resources that are easy to implement and culturally based practices that have proven to work in the efforts of preventing suicide will be discussed. Presenter: Diana Rosado, ICP CLICK HERE FOR HANDOUTS

Scope of Prevention 5-Part Webinar Series Part 4 of 5 Mamas, Munchkins, and Methamphetamines - Evidence-Based Interventions for Pregnant Women Using Stimulants Dr. Smid will provide an overview of evidence-based interventions for pregnant women using stimulants, including methamphetamine. Included in her presentation will be a brief overview of the epidemiology of stimulant-use disorder. She will also review sex and gender differences in methamphetamine use and the development of stimulant-use disorder.  PDF Slides Presenter: Marcela Smid, MD, MA, MS